Back to CRSP
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. → CRSP
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. CRSP Position History
CRISPR Therapeutics AG • Healthcare
Quarters held
42
Latest value
$1.3M
Q3 2026
Peak value
$15.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $4.9M |
| Q4 2025 | $5.2M |
| Q4 2025 | $3.1M |
| Q4 2025 | $2M |
| Q4 2025 | $2.6M |
| Q4 2025 | $12.3M |
| Q1 2026 | $4.5M |
| Q1 2026 | $4.8M |
| Q1 2026 | $2.9M |
| Q1 2026 | $1.8M |
| Q1 2026 | $2.4M |
| Q1 2026 | $11.1M |
| Q2 2026 | $5.1M |
| Q2 2026 | $2.5M |
| Q2 2026 | $5.5M |
| Q2 2026 | $490K |
| Q2 2026 | $12.9M |
| Q2 2026 | $7.6M |
| Q2 2026 | $1.3M |
| Q2 2026 | $3.3M |
| Q2 2026 | $981K |
| Q2 2026 | $2.1M |
| Q2 2026 | $2.7M |
| Q2 2026 | $1.6M |
| Q2 2026 | $4.1M |
| Q2 2026 | $763K |
| Q2 2026 | $13.3M |
| Q2 2026 | $1.6M |
| Q2 2026 | $218K |
| Q2 2026 | $12.8M |
| Q2 2026 | $2.6M |
| Q2 2026 | $3M |
| Q2 2026 | $327K |
| Q2 2026 | $1.8M |
| Q2 2026 | $2.7M |
| Q3 2026 | $5.2M |
| Q3 2026 | $2.5M |
| Q3 2026 | $55K |
| Q3 2026 | $5.5M |
| Q3 2026 | $1.4M |
| Q3 2026 | $15.7M |
| Q3 2026 | $1.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.3M | 24 | — | — |
| Q3 2026 | $15.7M | 283 | — | — |
| Q3 2026 | $1.4M | 25 | — | — |
| Q3 2026 | $5.5M | 100 | — | — |
| Q3 2026 | $55K | 1 | — | — |
| Q3 2026 | $2.5M | 45 | — | — |
| Q3 2026 | $5.2M | 94 | — | — |
| Q2 2026 | $2.7M | 50 | — | — |
| Q2 2026 | $1.8M | 33 | — | — |
| Q2 2026 | $327K | 6 | — | — |
| Q2 2026 | $3M | 55 | — | — |
| Q2 2026 | $2.6M | 48 | — | — |
| Q2 2026 | $12.8M | 234 | — | — |
| Q2 2026 | $218K | 4 | — | — |
| Q2 2026 | $1.6M | 30 | — | — |
| Q2 2026 | $13.3M | 244 | — | — |
| Q2 2026 | $763K | 14 | — | — |
| Q2 2026 | $4.1M | 76 | — | — |
| Q2 2026 | $1.6M | 29 | — | — |
| Q2 2026 | $2.7M | 50 | — | — |
| Q2 2026 | $2.1M | 38 | — | — |
| Q2 2026 | $981K | 18 | — | — |
| Q2 2026 | $3.3M | 60 | — | — |
| Q2 2026 | $1.3M | 24 | — | — |
| Q2 2026 | $7.6M | 139 | — | — |
| Q2 2026 | $12.9M | 237 | — | — |
| Q2 2026 | $490K | 9 | — | — |
| Q2 2026 | $5.5M | 100 | — | — |
| Q2 2026 | $2.5M | 45 | — | — |
| Q2 2026 | $5.1M | 94 | — | — |
| Q1 2026 | $11.1M | 234 | — | — |
| Q1 2026 | $2.4M | 50 | — | — |
| Q1 2026 | $1.8M | 38 | — | — |
| Q1 2026 | $2.9M | 60 | — | — |
| Q1 2026 | $4.8M | 100 | — | — |
| Q1 2026 | $4.5M | 94 | — | — |
| Q4 2025 | $12.3M | 234 | — | — |
| Q4 2025 | $2.6M | 50 | — | — |
| Q4 2025 | $2M | 38 | — | — |
| Q4 2025 | $3.1M | 60 | — | — |
| Q4 2025 | $5.2M | 100 | — | — |
| Q4 2025 | $4.9M | 94 | — | — |